Jingwei Yu

State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine/Department Of Lymphoma, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Baseline systemic immune-inflammation index and a novel FLIPI-SII model predict POD24 and long-term survival in grade 1-3a follicular lymphoma.

Baseline systemic immune-inflammation index and a novel FLIPI-SII model predict POD24 and long-term survival in grade 1-3a follicular lymphoma.

Journal: Frontiers in immunology
Published: April 30, 2026

Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma.

Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma.

Journal: Frontiers in immunology
Published: January 18, 2026

Long-term outcomes of vindesine or vincristine substitutions for vinblastine in classical Hodgkin lymphoma.

Long-term outcomes of vindesine or vincristine substitutions for vinblastine in classical Hodgkin lymphoma.

Journal: Chinese medical journal
Published: January 12, 2026

Single-cell and bulk transcriptomics reveal a CD8+ T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma.

Single-cell and bulk transcriptomics reveal a CD8+ T-cell gene signature predicting prognosis in diffuse large B-cell lymphoma.

Journal: Frontiers in immunology
Published: August 14, 2025

A Novel Prognostic Score for Disease Progression and Mortality in Patients With Newly Diagnosed Primary Large B-Cell Lymphoma of Immune-Privileged Sites.

A Novel Prognostic Score for Disease Progression and Mortality in Patients With Newly Diagnosed Primary Large B-Cell Lymphoma of Immune-Privileged Sites.

Journal: Hematological oncology
Published: March 03, 2025

CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study.

CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study.

Journal: Frontiers in immunology
Published: December 26, 2024

An evaluation of sugemalimab for the treatment of relapsed or refractory extranodal natural killer T-cell lymphoma.

An evaluation of sugemalimab for the treatment of relapsed or refractory extranodal natural killer T-cell lymphoma.

Journal: Expert opinion on biological therapy
Published: December 20, 2024

Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analyses.

Molecular landscape of distinct follicular lymphoma histologic grades: insights from genomic and transcriptome analyses.

Journal: Leukemia
Published: December 03, 2024

Survival Benefit of Relmacabtagene Autoleucel Versus Usual Care in Relapsed/Refractory Follicular Lymphoma: A Matching-Adjusted Indirect Analysis.

Survival Benefit of Relmacabtagene Autoleucel Versus Usual Care in Relapsed/Refractory Follicular Lymphoma: A Matching-Adjusted Indirect Analysis.

Journal: Hematological oncology
Published: November 23, 2024

Adverse events in the nervous system associated with blinatumomab: a real-world study.

Adverse events in the nervous system associated with blinatumomab: a real-world study.

Journal: BMC medicine
Published: October 20, 2024

Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers.

Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers.

Journal: European journal of cancer (Oxford, England : 1990)
Published: September 23, 2024

The age-adjusted international prognostic index 2 (A-FLIPI2) for elderly patients with follicular lymphoma.

The age-adjusted international prognostic index 2 (A-FLIPI2) for elderly patients with follicular lymphoma.

Journal: Heliyon
Published: July 17, 2024
Showing 1-12 of 25

Last Updated: 09/26/2026